Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 107,444 $ 125,492
Marketable securities 12,361 2,979
Accounts receivable, net 40,223 42,241
Inventories, net 24,601 21,840
Income tax receivable 976 669
Prepaid expenses and other current assets 13,589 13,846
Total current assets 199,194 207,067
Property and equipment, net 49,270 50,316
Goodwill 9,834 10,057
Intangible assets, net 32,907 34,591
Operating lease right-of-use asset 20,575 20,338
Other assets 3,819 3,825
Total assets 315,599 326,194
Current liabilities    
Accounts payable and accrued expenses 31,706 30,142
Accrued payroll 10,602 11,066
Warranty reserve - current 10,095 9,628
Operating lease liability - current 3,515 3,653
Earnout liability 10,570 10,000
Deferred revenue - current 7,422 7,980
Income tax payable   27
Total current liabilities 73,910 72,496
Long-term liabilities    
Warranty reserve - noncurrent 15,435 13,850
Operating lease liability - noncurrent 18,595 18,270
Deferred revenue - noncurrent 7,613 8,227
Deferred tax liability 8,148 8,539
Total liabilities 123,701 121,382
Commitments and contingencies (Note 10)
Stockholders' equity    
Common stock, $0.001 par value per share; 200,000,000 authorized; 23,546,478 and 23,324,750 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 24 23
Additional paid-in capital 323,213 320,513
Accumulated deficit (131,527) (116,949)
Accumulated other comprehensive income 188 1,225
Total stockholders' equity 191,898 204,812
Total liabilities and stockholders' equity $ 315,599 $ 326,194